Long-Term Liabilities (Quarterly)

Long-Term Liabilities: The sum of all non-current liabilities.

TransMedics Group, Inc. (TMDX) had Long-Term Liabilities of $515.62M for the most recently reported fiscal quarter, ending 2025-03-31.

Quarterly Annual

Figures for fiscal quarter ending 2025-03-31

Income Statement Financials
Revenue	$143.54M
Net Income	$25.68M
Cost of Goods Sold	$55.31M
Gross Profit	$88.23M
Operating Expenses	$116.09M
Operating Income	$27.44M
Non-Operating Income/Expense	$-0.77M
Pre-Tax Income	$26.68M
Normalized Pre-Tax Income	$26.68M
Income after Taxes	$25.68M
Income from Continuous Operations	$25.68M
Consolidated Net Income/Loss	$25.68M
Normalized Income after Taxes	$25.68M
EBIT	$27.44M
EBITDA	$33.58M
Weighted-Average Shares Outstanding (Basic)	33.72M
Weighted-Average Shares Outstanding (Diluted)	39.91M
Earnings per Share (EPS) (Basic)	$0.76
Earnings per Share (EPS) (Diluted)	$0.70
Balance Sheet Financials
Current Assets	$505.92M
Property, Plant, and Equipment	$311.24M
Long-Term Assets	$331.61M
Total Assets	$837.53M
Current Liabilities	$55.60M
Long-Term Debt	$510.10M
Long-Term Liabilities	$515.62M
Total Liabilities	$571.22M
Common Equity	$266.31M
Tangible Shareholders Equity	$252.66M
Shareholders Equity	$266.31M
Common Shares Outstanding	33.83M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$-2.85M
Cash Flow from Investing Activities	$-27.04M
Cash Flow from Financial Activities	$3.03M
Beginning Cash	$337.15M
End Cash	$310.64M
Increase/Decrease in Cash	$-26.51M
Stock-Based Compensation	$8.96M
Common Stock Dividends Paid	--
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	9.10
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.66
Debt to Equity Ratio	1.92
Gross Margin	61.47%
Operating Margin	19.12%
EBIT Margin	19.12%
EBITDA Margin	--
Pre-Tax Profit Margin	18.58%
Profit Margin	17.89%
Free Cash Flow	$-29.89M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.17
Inventory Turnover	1.27
Receiveable Turnover	1.01
Days Sales in Receivables	89.05
Return on Equity	9.64%
Return on Tangible Equity	10.16%
Return on Assets	3.07%
Return on Investments	3.31%
Book Value Per Share	$7.87
Free Cash Flow per Share	$-0.75
Operating Cash Flow per Share	$-0.07

Data from Zacks Investment Research, Inc.